Yun-jia Ning
State Key Laboratory Of Virology And Biosafety
Wuhan, 430071, China
Wuhan, 430071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
ACSL3 at the UPR crossroads: Tactician of anti-influenza defense, target of influenza offense.
Journal: Virologica Sinica
Published: July 02, 2026
From foe to phylax: Engineering SFTSV as a modular vaccine platform.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 15, 2025
Marburg Virus Glycoprotein Is a Remarkable Virulent Factor Linked to Hemorrhagic Pathology: Evidence from Multimodal Experimental Systems.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 25, 2025
Interferon-stimulated gene screening identifies CCND3 as a host restriction factor against emerging high-pathogenic bandaviruses.
Journal: Nature communications
Published: September 03, 2024
Kaempferide enhances type I interferon signaling as a novel broad-spectrum antiviral agent.
Journal: Antiviral research
Published: August 09, 2024
A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection.
Journal: Nature communications
Published: February 15, 2024
Host protein ARF1 is a proviral factor for SARS-CoV-2 and a candidate broad-spectrum therapeutic target.
Journal: Nature communications
Published: February 13, 2024
Host factor MxA restricts Dabie bandavirus infection by targeting the viral NP protein to inhibit NP-RdRp interaction and ribonucleoprotein activity.
Journal: Journal of virology
Published: December 06, 2023
Editorial: Severe fever with thrombocytopenia syndrome.
Journal: Frontiers in microbiology
Published: August 22, 2023
Last Updated: 09/26/2026